Biosafety Data as Confidential Business Information (Mar 2013) | BCH-VLR-SCBD-108021 | Biosafety Virtual Library Resources | Biosafety Clearing-House

Loading...
Biosafety Virtual Library Resources (VLR)
  |  
last updated: 13 May 2015

General Information
Biosafety Data as Confidential Business Information
EN
Kaare M. Nielsen 1. Department of Pharmacy, Faculty of Health Sciences, University of Tromsø, Tromsø, Norway 2. Genøk-Center for Biosafety, Science Park, Tromsø, Norway E-mail: kaare.nielsen@uit.no
EN
PLOS Biology
EN
2013-03
EN
EN
Copyright: © 2013 Kaare M. Nielsen. This is an open-access article distributed under the terms of the<br />Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any<br />medium, provided the original author and source are credited.
EN
Access to the resource(s)
Information on the content of the resource
This article is divided into the following sections:

-Biosafety Assessments
-Lack of Standards for CBI Claims
-CBI-Protected Biosafety Data Lacks Public Peer Review
-Conflicts of Interests in Biosafety Studies
-Publication Bias in Biosafety Data
-CBI Challenges the Capacity of Regulators/Regulatory Bodies
-CBI Claims with Conflicts of Interests Is a Generic Issue
-CBI Claims Prevent Independent Research and Monitoring
-Summary and Recommendations
EN
Keywords for facilitating searching for information in the clearing-houses

https://bch.cbd.int/onlineconferences/ra_guidance_references.shtml

No
No
No
No
Additional Information
Identifier (ISBN, ISSN, etc.)
doi:10.1371
Format
6-page PDF file
Keywords and any other relevant information
Citation: Nielsen KM (2013) Biosafety Data as Confidential Business Information. PLoS Biol 11(3): e1001499.doi:10.1371/journal.pbio.1001499 Series Editors: Claire Marris, (King’s College London, United Kingdom) and Nikolas Rose (King’s College London, United Kingdom) Abbreviations: CBI, confidential business information; EU, European Union; GMO, genetically modified organism.
EN